THIOTEPA FRESENIUS KABI 15 mg, powder for concentrate for infusion bottle, 6 ml
Active ingredients: THIOTÉPA
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusionbottle, 6 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- THIOTEPA FRESENIUS KABI 15 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 6 mL
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Jun 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68252132CIP75509478CIP133400955094784Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| THIOTÉPApoudre | 15 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: THIOTEPA 15 mg - TEPADINA 15 mg, poudre pour concentré pour solution pour perfusion